Send mail to Author

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _____     _    _                ___      _____     _____   
|  __ \\  | || | ||   ____      / _ \\   /  ___||  |  ___|| 
| |  \ || | || | ||  |    \\   / //\ \\ | // __    | ||__   
| |__/ || | \\_/ ||  | [] ||  |  ___  ||| \\_\ ||  | ||__   
|_____//   \____//   |  __//  |_||  |_|| \____//   |_____|| 
 -----`     `---`    |_|`-`   `-`   `-`   `---`    `-----`  
                     `-`
 


Back to frontdoor view

OPUS4 Logo